Animal study · mice
Ac-SDKP cut heart rupture and aided heart function in mice after MI
Checked against the paper Animal studyPublished by PepVault
The takeaway
This adds mouse evidence that Ac-SDKP given after a heart attack reduced heart rupture and scarring and helped heart function, but it has not been shown in people.
- Kind
- Animal study
- Studied in
- Mice
- Published
- 2019
- Journal
- Can J Physiol Pharmacol
What they tested
The team tested whether Ac-SDKP could cut heart rupture and harmful heart reshaping, and improve heart function, after a heart attack in mice.
How the study was done
An animal study in C57BL/6J mice that had a myocardial infarction (MI, a heart attack) and were then treated with Ac-SDKP, a daily dose of 1.6 mg/kg, over either a 1-week or a 5-week period. The team looked at inflammation, new blood vessel growth, cell death, scarring, and heart shape and function.

What they found
In mice, in the first week after MI, Ac-SDKP lowered the rate of cardiac rupture, meaning the heart wall tearing. It also lowered ICAM-1 (an adhesion molecule), the number of macrophages (immune cells) moving into the heart, gelatinolytic activity, p53 and heart muscle cell death, while raising capillary density at the edge of the damaged area. Over 5 weeks, treated mice had better heart structure and function, less collagen buildup between cells, lower CHOP (a marker of endoplasmic reticulum stress), and kept their levels of SERCA2 (a calcium-handling protein in heart muscle). The authors suggest the benefit likely comes through keeping SERCA2 and blocking endoplasmic reticulum stress.
What it doesn’t show
This is mouse work, so it is not a human result. Treatment lasted at most 5 weeks, and the suggested route of action is the authors' interpretation, not something shown directly.
The paper
Peng et al. N-acetyl-seryl-aspartyl-lysyl-proline treatment protects heart against excessive myocardial injury and heart failure in mice. Can J Physiol Pharmacol. 2019.
The compound
More studies on Ac-SDKP
- Ac-SDKP: blood levels fell after kidney transplant in 14 patientsClinical trial · people · 2014
- Ac-SDKP taken by mouth eased kidney scarring in diabetic miceAnimal study · mice · 2016
- Every study on Ac-SDKP
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.